Progenity to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
SAN DIEGO, March 12, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ: PROG), a biotechnology company with an established track record...
Year: 2021
Crinetics Pharmaceuticals Showcasing Breadth of Pipeline at ENDO 2021 with Presentations on Three Clinical Programs
- Details of New Paltusotine Tablet Formulation to be Unveiled - - Preclinical Evidence Supporting Programs in Congenital Hyperinsulinism and...
Precision BioSciences to Report Fourth Quarter and Fiscal Year 2020 Financial Results on March 18, 2021
DURHAM, N.C., March 12, 2021 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company, today announced...
Iterum Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
--NDA for Oral Sulopenem has PDUFA date of July 25, 2021-- --Cash Runway into First Half of 2023— --Company to...
Aravive to Present Phase 1b Data Evaluating AVB-500 in Platinum Resistant Ovarian Cancer at 2021 Society of Gynecologic Oncology Annual Meeting
HOUSTON, March 12, 2021 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq:ARAV), a clinical-stage oncology company developing transformative therapeutics, today announced that...
Milestone Scientific to Present at the Q1 Virtual Investor Summit
ROSELAND, N.J., March 12, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of...
PLx Pharma Inc. Reports Fourth Quarter and Full Year 2020 Results and Provides Business Update
-- Received FDA approval of sNDAs for both VAZALORE 325 mg and 81 mg, the first-ever novel, liquid-filled aspirin capsule...
Bavarian Nordic A/S – Articles of Association
Updated Articles of Association for Bavarian Nordic A/S. Attachment Bavarian Nordic - Articles of Association
So-Young to Report Fourth Quarter and Full Year 2020 Financial Results on March 22, 2021
BEIJING, March 12, 2021 (GLOBE NEWSWIRE) -- So-Young International Inc. (NASDAQ: SY) (“So-Young” or the “Company”), the largest and most...
Bavarian Nordic A/S – Registration of Share Capital Increase of 5,150,000 New Shares Completed
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH...
Nexstim Gives an Update on its Promising Treatment Results of Major Depressive Disorder
Press Release, Helsinki, 12 March 2021 at 10.00 (EET) Nexstim Gives an Update on its Promising Treatment Results of Major...
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
COPENHAGEN, Denmark, March 12, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) has today received information about the following...
Aino Health AB (publ): Wihuri Oy expands the usage of the SaaS solution Aino HealthManager to all of Finland
Stockholm 12 March 2021: Aino Health announces today that Wihuri Oy has decided to expand the use of Aino's solutions to...
Bavarian Nordic Publishes Annual Report 2020
COPENHAGEN, Denmark, March 12, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today published its Annual Report for 2020....
Exercise of Options and Total Voting Rights
Exercise of Options and Total Voting Rights DUBLIN, Ireland, and Boston MA, March 12, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT),...
Annual General Meeting’s results and cash information to serve the development strategy
Press release Ecully, 12 March 2021 – 8 a.m. Approval of the General Meeting’s resolutionsSolid cash position to continue development...
Sanofi and Translate Bio initiate Phase 1/2 clinical trial of mRNA COVID-19 vaccine candidate
Sanofi and Translate Bio initiate Phase 1/2 clinical trial of mRNA COVID-19 vaccine candidate Clinical trial to assess safety, immune...
Altimmune Expands AdCOVID™ Manufacturing Collaboration with Lonza
Lonza to Commission a Dedicated Suite for Clinical and Commercial Supply of Altimmune’s COVID-19 Vaccine Candidate at its Houston FacilityGAITHERSBURG,...
Sanofi and Translate Bio Initiate Phase 1/2 Clinical Trial of mRNA COVID-19 Vaccine Candidate
-- Clinical trial to assess safety, immune response and reactogenicity, after preclinical data showed high neutralizing antibody levels -- --...
Longboard Pharmaceuticals Announces Pricing of Initial Public Offering
SAN DIEGO, March 11, 2021 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing novel, transformative...